SEC Form 4 · accession 0001144204-15-047899
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Przybyl
Officer — President and CEO · Director
Period of report
Aug 10, 2015
Accepted (ET)
Aug 10, 2015 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 10, 2015 | M | 10,000 | $6.36 | A | 142,695 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock | $6.36 | Aug 10, 2015 | M | 10,000 | D | Jul 12, 2014 | Jul 11, 2023 | Common Stock | 10,000 | 80,833 | D |